{"date":"2026-11-19","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6703-2026-11-19-1748-nwq5tj","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-11-19","time":"17:48:28","subject":"本公司取得 CYBER LOOK PROPERTIES LTD.100% 股權(補充115/07/16公告)","clause":"第20款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-11-19 17:48，「本公司取得 CYBER LOOK PROPERTIES LTD.100% 股權(補充115/07/16公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-11-19-1748-1yo1yys","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-11-19","time":"17:48:10","subject":"本公司董事會決議取得 CYBER LOOK PROPERTIES LTD.100% 股權(補充115/07/16公告)","clause":"第20款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-11-19 17:48，「本公司董事會決議取得 CYBER LOOK PROPERTIES LTD.100% 股權(補充115/07/16公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-11-19-1702-54swv6","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-11-19","time":"17:02:09","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-11-19 17:02，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-11-19-1700-142ih3h","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-11-19","time":"17:00:42","subject":"公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-11-19 17:00，「公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-11-19-1647-eq41md","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-11-19","time":"16:47:42","subject":"公告本公司受邀參加永豐金證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-11-24","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-11-19 16:47，「公告本公司受邀參加永豐金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-11-19-1632-x6z0l3","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-11-19","time":"16:32:03","subject":"公告本公司法人董事代表人辭職","clause":"第6款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-11-19 16:32，「公告本公司法人董事代表人辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-11-19-1631-1b2v49g","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-11-19","time":"16:31:25","subject":"公告本公司董事長辭任","clause":"第6款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-11-19 16:31，「公告本公司董事長辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-11-19-1549-190fsk7","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-11-19","time":"15:49:05","subject":"本公司受邀參加永豐金證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-11-19 15:49，「本公司受邀參加永豐金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-11-19-1448-4mwyjk","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-11-19","time":"14:48:41","subject":"公告本公司115年10月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第44款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-11-19 14:48，「公告本公司115年10月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-11-19-1442-68yr6f","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-11-19","time":"14:42:55","subject":"本公司受邀參加福邦證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-27","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-11-19 14:42，「本公司受邀參加福邦證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}